EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation

European Heart Journal Cardiovascular Imaging

Volumn 17, Issue 4, 2016, Pages 355-383

  Donal, Erwan ^a   Lip, Gregory Y H ^b,c   Galderisi, Maurizio ^d   Goette, Andreas ^e   Shah, Dipen ^f   Marwan, Mohamed ^g   Lederlin, Mathieu ^a   Mondillo, Sergio ^d   Edvardsen, Thor ^h   Sitges, Marta ⁱ   Grapsa, Julia ^j   Garbi, Madalina ^k   Senior, Roxy ^l   Gimelli, Alessia ^m   Potpara, Tatjana S ⁿ   Van Gelder, Isabelle C ^o   Gorenek, Bulent ^p   Mabo, Philippe ^a   Lancellotti, Patrizio ^q,r   Kuck, Karl Heinz ^s   Popescu, Bogdan A ^t   Hindricks, Gerhard ^u   Habib, Gilbert ^v   more..

^a UNIVERSITÉ DE RENNES 1   (France)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c AALBORG UNIVERSITY   (Denmark)

^d FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^e St Vincenz Hospital   (Germany)

^f Faculty of Medicine   (Switzerland)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h UNIVERSITY OF OSLO   (Norway)

ⁱ UNIVERSITY OF BARCELONA   (Spain)

^j IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^k KING'S COLLEGE LONDON   (United Kingdom)

^l ROYAL BROMPTON HOSPITAL   (United Kingdom)

^m FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

ⁿ UNIVERSITY OF BELGRADE   (Serbia)

^o UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^p ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^q UNIVERSITY OF LIÈGE   (Belgium)

^r GVM Care and Research ES Health Science Foundation   (Italy)

^s DEPARTMENT OF CARDIOLOGY   (Germany)

^t CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^u UNIVERSITY OF LEIPZIG   (Germany)

^v TIMONE HOSPITAL   (France)

more..

Author keywords

Atrial fibrillation; Cardiac imaging; Cardiac magnetic resonance; Computed tomography; Doppler echocardiography; Pathophysiology

Indexed keywords

ADIPOSE TISSUE; AORTA VALVE DISEASE; ATRIAL CARDIOMYOPATHY; ATRIAL FIBRILLATION; ATRIAL SEPTAL OCCLUDER; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVERSION; CATHETER ABLATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; EPICARDIAL ADIPOSE TISSUE; FOLLOW UP; GEOMETRY; HEART ATRIUM APPENDAGE; HEART ATRIUM APPENDAGE OCCLUDER; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE FUNCTION; HEART SIZE; HUMAN; INTRACARDIAC ECHOCARDIOGRAPHY; LEFT VENTRICULAR SYSTOLIC FUNCTION; MITRAL VALVE DISEASE; MULTI MODALITY IMAGING; NON VALVULAR ATRIAL FIBRILLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY VEIN; REVIEW; SPECKLE TRACKING ECHOCARDIOGRAPHY; STRESS ECHOCARDIOGRAPHY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; THROMBOEMBOLISM; VALVULAR HEART DISEASE; CONSENSUS; EUROPE; MULTIMODAL IMAGING; PRACTICE GUIDELINE;

ATRIAL FIBRILLATION; CONSENSUS; EUROPE; HUMANS; MULTIMODAL IMAGING; PRACTICE GUIDELINES AS TOPIC;

EID: 84964294663     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jev354     Document Type: Review

References (223)

1. Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest. 2012; 142: 1489-98.
2. Van Wagoner DR, Piccini JP, Albert CM, Anderson ME, Benjamin EJ, Brundel B, et al. Progress toward the prevention and treatment of atrial fibrillation: a summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, 9-10 December 2013. Heart Rhythm. 2015; 12: e5-e29.
3. Task Force Members, Lip GY, Windecker S, Huber K, Kirchhof P, Marin F, et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J. 2014; 35: 3155-79.
4. De Caterina R, Camm AJ. What is 'valvular atrial fibrillation?. A reappraisal Eur Heart J. 2014; 35: 3328-35.
5. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012; 33: 2719-47.
6. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014 130 2071-104.
7. Ezekowitz MD, Connolly S, Parekh A, Reilly PA, Varrone J, Wang S, et al. Rationale and design of RE-LY: randomized evaluation of long-Term anticoagulant therapy, warfarin, compared with dabigatran. Am Heart J. 2009; 157: 805-10. 10.e1-2.
8. Lopes RD, Alexander JH, Al-Khatib SM, Ansell J, Diaz R, Easton JD, et al. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale. Am Heart J. 2010; 159: 331-9.
9. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study. Am Heart J. 2010 159 340-7. e1.
10. Fauchier L, Philippart R, Clementy N, Bourguignon T, Angoulvant D, Ivanes F, et al. How to define valvular atrial fibrillation?. Arch Cardiovasc Dis. 2015; 108: 530-9.
11. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010; 12: 1360-420.
12. Pisters R, Lane DA, Marin F, Camm AJ, Lip GY. Stroke and thromboembolism in atrial fibrillation. Circ J. 2012; 76: 2289-304.
13. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillationdeveloped with the special contribution of the European Heart Rhythm Association. Europace. 2012 14 1385-413.
14. January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC Jr, Cigarroa JE, et al. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014 64 e1-76.
15. The National Institute for Health and Care Excellence. Atrial fibrillation: the management of atrial fibrillation. (Clinical guideline 180.) 2014. http: //guidance.nice. org.uk/CG180.
16. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010; 137: 263-72.
17. Manning WJ, Silverman DI, Waksmonski CA, Oettgen P, Douglas PS. Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation. Arch Intern Med. 1995; 155: 2193-8.
18. Vaziri S, Bikkina M, Levy D. Predictors of thromboembolism in atrial fibrillation. Ann Intern Med. 1992; 117: 89-90.
19. Heinzlef O, Cohen A, Amarenco P. An update on aortic causes of ischemic stroke. Curr Opin Neurol. 1997; 10: 64-72.
20. Hoit BD. Left atrial size and function: role in prognosis. J Am Coll Cardiol. 2014; 63: 493-505.
21. Cui Q, Wang H, ZhangW, Wang H, Sun X, Zhang Y, et al. Enhanced left atrial reservoir, increased conduit, and weakened booster pump function in hypertensive patients with paroxysmal atrial fibrillation. Hypertens Res. 2008; 31: 395-400.
22. Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011; 91: 265-325.
23. Stefanadis C, Dernellis J, Toutouzas P. A clinical appraisal of left atrial function. Eur Heart J. 2001; 22: 22-36.
24. Ho SY, Cabrera JA, Sanchez-Quintana D. Left atrial anatomy revisited. Circ Arrhythm Electrophysiol. 2012; 5: 220-8.
25. Ho SY, Sanchez-Quintana D, Cabrera JA, Anderson RH. Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1999; 10: 1525-33.
26. Sanchez-Quintana D, Cabrera JA, Climent V, Farre J, Mendonca MC, Ho SY. Anatomic relations between the esophagus and left atrium and relevance for ablation of atrial fibrillation. Circulation. 2005; 112: 1400-5.
27. Tan AY, Li H, Wachsmann-Hogiu S, Chen LS, Chen PS, Fishbein MC. Autonomic innervation and segmental muscular disconnections at the human pulmonary vein-Atrial junction: implications for catheter ablation of atrial-pulmonary vein junction. J Am Coll Cardiol. 2006; 48: 132-43.
28. Ho SY, Cabrera JA, Tran VH, Farre J, Anderson RH, Sanchez-Quintana D. Architecture of the pulmonary veins: relevance to radiofrequency ablation. Heart. 2001; 86: 265-70.
29. Batal O, Schoenhagen P, Shao M, Ayyad AE, Van Wagoner DR, Halliburton SS, et al. Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol. 2010; 3: 230-6.
30. Veinot JP, Harrity PJ, Gentile F, Khandheria BK, Bailey KR, Eickholt JT, et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation. 1997; 96: 3112-5.
31. Donal E, Yamada H, Leclercq C, Herpin D. The left atrial appendage, a small, blind-ended structure: a review of its echocardiographic evaluation and its clinical role. Chest. 2005; 128: 1853-62.
32. Arndt M, Lendeckel U, Rocken C, Nepple K, Wolke C, Spiess A, et al. Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria. Circulation. 2002; 105: 720-5.
33. Hoit BD, Walsh RA. Regional atrial distensibility. Am J Physiol. 1992; 262(Pt 2): H1356-60.
34. Osranek M, Bursi F, Bailey KR, Grossardt BR, Brown RD Jr, Kopecky SL, et al. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J. 2005; 26: 2556-61.
35. Russo C, Hahn RT, Jin Z, Homma S, Sacco RL, Di Tullio MR. Comparison of echocardiographic single-plane versus biplane method in the assessment of left atrial volume and validation by real time three-dimensional echocardiography. J Am Soc Echocardiogr. 2010; 23: 954-60.
36. Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ, et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol. 2006; 47: 2357-63.
37. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter?. J Am Coll Cardiol. 2006; 47: 1018-23.
38. Raitt MH, Volgman AS, Zoble RG, Charbonneau L, Padder FA, OHara GE, et al. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2006; 151: 390-6.
39. Benjamin EJ, Plehn JF, DAgostino RB, Belanger AJ, Comai K, Fuller DL, et al. Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med. 1992; 327: 374-9.
40. Potpara TS, Vasiljevic ZM, Vujisic-Tesic BD, Marinkovic JM, Polovina MM, Stepanovic JM, et al. Mitral annular calcification predicts cardiovascular morbidity and mortality in middle-Aged patients with atrial fibrillation: the Belgrade Atrial Fibrillation Study. Chest. 2011; 140: 902-10.
41. Adler Y, Vaturi M, Fink N, Tanne D, Shapira Y, Weisenberg D, et al. Association between mitral annulus calcification and aortic atheroma: a prospective transesophageal echocardiographic study. Atherosclerosis. 2000; 152: 451-6.
42. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015; 16: 233-70.
43. Blume GG, McLeod CJ, Barnes ME, Seward JB, Pellikka PA, Bastiansen PM, et al. Left atrial function: physiology, assessment, and clinical implications. Eur Heart J Cardiovasc Imaging. 2011; 12: 421-30.
44. Abhayaratna WP, Fatema K, Barnes ME, Seward JB, Gersh BJ, Bailey KR, et al. Left atrial reservoir function as a potent marker for first atrial fibrillation or flutter in persons . or 65 years of age. Am J Cardiol. 2008; 101: 1626-9.
45. Hirose T, Kawasaki M, Tanaka R, Ono K, Watanabe T, Iwama M, et al. Left atrial function assessed by speckle tracking echocardiography as a predictor of newonset non-valvular atrial fibrillation: results from a prospective study in 580 adults. Eur Heart J Cardiovasc Imaging. 2012; 13: 243-50.
46. Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol. 2008; 51: 1-11.
47. Cameli M, Lisi M, Righini FM, Massoni A, Natali BM, Focardi M, et al. Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol. 2013; 111: 595-601.
48. Ellis K, Ziada KM, Vivekananthan D, Latif AA, Shaaraoui M, Martin D, et al. Transthoracic echocardiographic predictors of left atrial appendage thrombus. Am J Cardiol. 2006; 97: 421-5.
49. Puwanant S, Varr BC, Shrestha K, Hussain SK, Tang WH, Gabriel RS, et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol. 2009; 54: 2032-9.
50. Lowe BS, Kusunose K, Motoki H, Varr B, Shrestha K, Whitman C, et al. Prognostic significance of left atrial appendage sludge in patients with atrial fibrillation: a new transesophageal echocardiographic thromboembolic risk factor. J Am Soc Echocardiogr. 2014; 27: 1176-83.
51. Szymanski FM, Lip GY, Filipiak KJ, Platek AE, Hrynkiewicz-Szymanska A, Opolski G. Stroke risk factors beyond the CHA2DS2-VASc score: can we improve our identification of high stroke risk patients with atrial fibrillation?. Am J Cardiol. 2015; 116: 1781-8.
52. Providencia R, Trigo J, Paiva L, Barra S. The role of echocardiography in thromboembolic risk assessment of patients with nonvalvular atrial fibrillation. J Am Soc Echocardiogr. 2013; 26: 801-12.
53. Black IW. Spontaneous echo contrast: where theres smoke theres fire. Echocardiography. 2000; 17: 373-82.
54. Fatkin D, Kelly R, Feneley MP. Left atrial appendage blood velocity and thromboembolic risk in patients with atrial fibrillation. J Am Coll Cardiol. 1994; 24: 1429-30.
55. Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol. 1994; 23: 961-9.
56. Donal E, Sallach JA, Murray RD, Drinko JK, Jasper SE, Thomas JD, et al. Contrast-enhanced tissue Doppler imaging of the left atrial appendage is a new quantitative measure of spontaneous echocardiographic contrast in atrial fibrillation. Eur J Echocardiogr. 2008; 9: 5-11.
57. Sallach JA, Puwanant S, Drinko JK, Jaffer S, Donal E, Thambidorai SK, et al. Comprehensive left atrial appendage optimization of thrombus using surface echocardiography: the CLOTS multicenter pilot trial. J Am Soc Echocardiogr. 2009; 22: 1165-72.
58. Troughton RW, Asher CR, Klein AL. The role of echocardiography in atrial fibrillation and cardioversion. Heart. 2003; 89: 1447-54.
59. Bernhardt P, Schmidt H, Hammerstingl C, Luderitz B, Omran H. Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol. 2005; 45: 1807-12.
60. Dawn B, Varma J, Singh P, Longaker RA, Stoddard MF. Cardiovascular death in patients with atrial fibrillation is better predicted by left atrial thrombus and spontaneous echocardiographic contrast as compared with clinical parameters. J Am Soc Echocardiogr. 2005; 18: 199-205.
61. Montserrat S, Gabrielli L, Borras R, Poyatos S, Berruezo A, Bijnens B, et al. Left atrial size and function by three-dimensional echocardiography to predict arrhythmia recurrence after first and repeated ablation of atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2014; 15: 515-22.
62. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med. 1998 158 1316-20.
63. Ayirala S, Kumar S, OSullivan DM, Silverman DI. Echocardiographic predictors of left atrial appendage thrombus formation. J Am Soc Echocardiogr. 2011; 24: 499-505.
64. Providencia R, Faustino A, Paiva L, Trigo J, Botelho A, Nascimento J, et al. Cardioversion safety in patients with nonvalvular atrial fibrillation: which patients can be spared transesophageal echocardiography?. Blood Coagul Fibrinolysis. 2012; 23: 597-602.
65. Kleemann T, Becker T, Strauss M, Schneider S, Seidl K. Prevalence and clinical impact of left atrial thrombus and dense spontaneous echo contrast in patients with atrial fibrillation and low CHADS2 score. Eur J Echocardiogr. 2009; 10: 383-8.
66. Lee SH, Choi S, Chung WJ, Byun YS, Ryu SK, Pyun WB, et al. Tissue Doppler index, E/E, and ischemic stroke in patients with atrial fibrillation and preserved left ventricular ejection fraction. J Neurol Sci. 2008; 271: 148-52.
67. ShinHW, Kim H, Son J, Yoon HJ, Park HS, Cho YK, et al. Tissue Doppler imaging as a prognostic marker for cardiovascular events in heart failure with preserved ejection fraction and atrial fibrillation. J Am Soc Echocardiogr. 2010; 23: 755-61.
68. De Vos CB, Breithardt G, Camm AJ, Dorian P, Kowey PR, Le Heuzey JY, et al. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy. Am Heart J. 2012; 163: 887-93.
69. Nattel S, Guasch E, Savelieva I, Cosio FG, Valverde I, Halperin JL, et al. Early management of atrial fibrillation to prevent cardiovascular complications. Eur Heart J. 2014; 35: 1448-56.
70. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010; 31: 2369-429.
71. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ, et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol. 2010; 55: 725-31.
72. Tops LF, Schalij MJ, Bax JJ. Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation. Eur Heart J. 2010; 31: 542-51.
73. Klein AL, Grimm RA, Jasper SE, Murray RD, Apperson-Hansen C, Lieber EA, et al. Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial. Am Heart J. 2006; 151: 380-9.
74. Yamada H, Donal E, Kim YJ, Agler DA, Zhang Y, Greenberg NL, et al. The pseudorestrictive pattern of transmitral Doppler flow pattern after conversion of atrial fibrillation to sinus rhythm: is atrial or ventricular dysfunction to blame?. J Am Soc Echocardiogr. 2004; 17: 813-8.
75. Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol. 1994; 23: 1535-40.
76. Wasmund SL, Li JM, Page RL, Joglar JA, Kowal RC, Smith ML, et al. Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects. Circulation. 2003; 107: 2011-5.
77. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol. 1997; 29: 709-15.
78. Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management. J Am Coll Cardiol. 2015; 66: 1714-28.
79. Calvo N, Bisbal F, Guiu E, Ramos P, Nadal M, Tolosana JM, et al. Impact of atrial fibrillation-induced tachycardiomyopathy in patients undergoing pulmonary vein isolation. Int J Cardiol. 2013; 168: 4093-7.
80. Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, et al. Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation. Eur J Heart Fail. 2015; 17: 570-82.
81. Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, et al. Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project. Eur J Heart Fail. 2012; 14: 295-301.
82. Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Lip GY. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study. Eur J Heart Fail. 2013; 15: 415-24.
83. Marwick TH. Techniques for comprehensive two dimensional echocardiographic assessment of left ventricular systolic function. Heart. 2003; 89(Suppl. 3): iii2-8.
84. Zaca V, Ballo P, Galderisi M, Mondillo S. Echocardiography in the assessment of left ventricular longitudinal systolic function: current methodology and clinical applications. Heart Fail Rev. 2010; 15: 23-37.
85. Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-Analysis of global longitudinal strain and ejection fraction. Heart. 2014; 100: 1673-80.
86. Su HM, Lin TH, Hsu PC, Lee WH, Chu CY, Lee CS, et al. Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation. Heart. 2013; 99: 1588-96.
87. Hirsh BJ, Copeland-Halperin RS, Halperin JL. Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences. J Am Coll Cardiol. 2015; 65: 2239-51.
88. Tsang TS, Gersh BJ, Appleton CP, Tajik AJ, Barnes ME, Bailey KR, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol. 2002; 40: 1636-44.
89. Chen HH, Lainchbury JG, Senni M, Bailey KR, Redfield MM. Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail. 2002; 8: 279-87.
90. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation. 1991; 84: 40-8.
91. Donal E, Lund LH, Oger E, Reynaud A, Schnell F, Persson H, et al. Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study. Eur Heart J Cardiovasc Imaging. 2016; 17: 106-13.
92. Nagarakanti R, Ezekowitz M. Diastolic dysfunction and atrial fibrillation. J Interv Card Electrophysiol. 2008; 22: 111-8.
93. Nagueh SF, Kopelen HA, Quinones MA. Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation. Circulation. 1996; 94: 2138-45.
94. Galderisi M, Henein MY, DHooge J, Sicari R, Badano LP, Zamorano JL, et al. Recommendations of the European Association of Echocardiography: how to use echo-Doppler in clinical trials: different modalities for different purposes. Eur J Echocardiogr. 2011; 12: 339-53.
95. Matsukida K, Kisanuki A, Toyonaga K, Murayama T, Nakashima H, Kumanohoso T, et al. Comparison of transthoracic Doppler echocardiography and natriuretic peptides in predicting mean pulmonary capillary wedge pressure in patients with chronic atrial fibrillation. J Am Soc Echocardiogr. 2001; 14: 1080-7.
96. Temporelli PL, Scapellato F, Corra U, Eleuteri E, Imparato A, Giannuzzi P. Estimation of pulmonary wedge pressure by transmitral Doppler in patients with chronic heart failure and atrial fibrillation. Am J Cardiol. 1999; 83: 724-7.
97. Chirillo F, Brunazzi MC, Barbiero M, Giavarina D, Pasqualini M, Franceschini-Grisolia E, et al. Estimating mean pulmonary wedge pressure in patients with chronic atrial fibrillation from transthoracic Doppler indexes of mitral and pulmonary venous flow velocity. J Am Coll Cardiol. 1997; 30: 19-26.
98. SohnDW, Song JM, Zo JH, Chai IH, Kim HS, Chun HG, et al. Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. J Am Soc Echocardiogr. 1999; 12: 927-31.
99. Houltz B, Johansson B, Berglin E, Karlsson T, Edvardsson N, Wandt B. Left ventricular diastolic function and right atrial size are important rhythm outcome predictors after intraoperative ablation for atrial fibrillation. Echocardiography. 2010; 27: 961-8.
100. Muller H, Noble S, Keller PF, Sigaud P, Gentil P, Lerch R, et al. Biatrial anatomical reverse remodelling after radiofrequency catheter ablation for atrial fibrillation: evidence from real-Time three-dimensional echocardiography. Europace. 2008; 10: 1073-8.
101. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010; 23: 685-713. quiz 86-8.
102. Beigel R, Cercek B, Luo H, Siegel RJ. Noninvasive evaluation of right atrial pressure. J Am Soc Echocardiogr. 2013; 26: 1033-42.
103. Cresti A, Garcia-Fernandez MA, Miracapillo G, Picchi A, Cesareo F, Guerrini F, et al. Frequency and significance of right atrial appendage thrombi in patients with persistent atrial fibrillation or atrial flutter. J Am Soc Echocardiogr. 2014; 27: 1200-7.
104. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008; 117: 1717-31.
105. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008; 117: 1436-48.
106. Mahmud M, Champion HC. Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategies. Curr Cardiol Rep. 2007; 9: 200-8.
107. Cohen S, Gaddam S, Gemignani A, Wu WC, Sharma S, Choudhary G. Right ventricular function relates to functional capacity in men with atrial fibrillation and preserved left ventricular ejection fraction. Echocardiography. 2013; 30: 542-50.
108. Focardi M, Cameli M, Carbone SF, Massoni A, De Vito R, Lisi M, et al. Traditional and innovative echocardiographic parameters for the analysis of right ventricular performance in comparison with cardiac magnetic resonance. Eur Heart J Cardiovasc Imaging. 2015; 16: 47-52.
109. Boyd AC, Richards DA, Marwick T, Thomas L. Atrial strain rate is a sensitive measure of alterations in atrial phasic function in healthy ageing. Heart. 2011; 97: 1513-9.
110. Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2015; 16: 1-11.
111. Sun JP, Yang Y, Guo R, Wang D, Lee AP, Wang XY, et al. Left atrial regional phasic strain, strain rate and velocity by speckle-Tracking echocardiography: normal values and effects of aging in a large group of normal subjects. Int J Cardiol. 2013; 168: 3473-9.
112. Saraiva RM, Demirkol S, Buakhamsri A, Greenberg N, Popovic ZB, Thomas JD, et al. Left atrial strain measured by two-dimensional speckle tracking represents a new tool to evaluate left atrial function. J Am Soc Echocardiogr. 2010; 23: 172-80.
113. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S, et al. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circulation. 2010; 3: 231-9.
114. Obokata M, Negishi K, Kurosawa K, Tateno R, Tange S, Arai M, et al. Left atrial strain provides incremental value for embolism risk stratification over CHA(2)DS(2)-VASc score and indicates prognostic impact in patients with atrial fibrillation. J Am Soc Echocardiogr. 2014; 27: 709-16. e4.
115. Marsan NA, Tops LF, Nihoyannopoulos P, Holman ER, Bax JJ. Real-Time three dimensional echocardiography: current and future clinical applications. Heart. 2009; 95: 1881-90.
116. Boyd AC, Thomas L. Left atrial volumes: two-dimensional, three-dimensional, cardiac magnetic resonance and computed tomography measurements. Curr Opin Cardiol. 2014; 29: 408-16.
117. Perez de Isla L, Feltes G, Moreno J, Martinez W, Saltijeral A, de Agustin JA, et al. Quantification of left atrial volumes using three-dimensional wall motion tracking echocardiographic technology: comparison with cardiac magnetic resonance. Eur Heart J Cardiovasc Imaging. 2014; 15: 793-9.
118. Beigel R, Wunderlich NC, Ho SY, Arsanjani R, Siegel RJ. The left atrial appendage: anatomy, function, and noninvasive evaluation. JACC Cardiovasc Imaging. 2014; 7: 1251-65.
119. Boldt A, Wetzel U, Lauschke J, Weigl J, Gummert J, Hindricks G, et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart. 2004; 90: 400-5.
120. Zlochiver S, Munoz V, Vikstrom KL, Taffet SM, Berenfeld O, Jalife J. Electrotonic myofibroblast-To-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers. Biophys J. 2008; 95: 4469-80.
121. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 343: 1445-53.
122. McGann CJ, Kholmovski EG, Oakes RS, Blauer JJ, Daccarett M, Segerson N, et al. New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol. 2008; 52: 1263-71.
123. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014; 311: 498-506.
124. Beinart R, Khurram IM, Liu S, Yarmohammadi H, Halperin HR, Bluemke DA, et al. Cardiac magnetic resonance T1 mapping of left atrial myocardium. Heart Rhythm. 2013; 10: 1325-31.
125. Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson. 2014; 16: 2.
126. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009; 119: 1758-67.
127. Mahnkopf C, Badger TJ, Burgon NS, Daccarett M, Haslam TS, Badger CT, et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm. 2010; 7: 1475-81.
128. McGann C, Akoum N, Patel A, Kholmovski E, Revelo P, Damal K, et al. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol. 2014; 7: 23-30.
129. Akkaya M, Higuchi K, Koopmann M, Damal K, Burgon NS, Kholmovski E, et al. Higher degree of left atrial structural remodeling in patients with atrial fibrillation and left ventricular systolic dysfunction. J Cardiovasc Electrophysiol. 2013; 24: 485-91.
130. Akoum N, Fernandez G, Wilson B, McGann C, Kholmovski E, Marrouche N. Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2013; 24: 1104-9.
131. Daccarett M, Badger TJ, Akoum N, Burgon NS, Mahnkopf C, Vergara G, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011; 57: 831-8.
132. Badger TJ, Daccarett M, AkoumNW, Adjei-Poku YA, Burgon NS, Haslam TS, et al. Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures. Circ Arrhythm Electrophysiol. 2010; 3: 249-59.
133. Jadidi AS, Cochet H, Shah AJ, Kim SJ, Duncan E, Miyazaki S, et al. Inverse relationship between fractionated electrograms and atrial fibrosis in persistent atrial fibrillation: combined magnetic resonance imaging and high-density mapping. J Am Coll Cardiol. 2013; 62: 802-12.
134. Khurram IM, Beinart R, Zipunnikov V, Dewire J, Yarmohammadi H, Sasaki T, et al. Magnetic resonance image intensity ratio, a normalized measure to enable interpatient comparability of left atrial fibrosis. Heart Rhythm. 2013; 11: 85-92.
135. Malcolme-Lawes LC, Juli C, Karim R, Bai W, Quest R, Lim PB, et al. Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study. Heart Rhythm. 2013; 10: 1184-91.
136. Spragg DD, Khurram I, Zimmerman SL, Yarmohammadi H, Barcelon B, Needleman M, et al. Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations. Heart Rhythm. 2012; 9: 2003-9.
137. Cochet H, Dubois R, Sacher F, Derval N, Sermesant M, Hocini M, et al. Cardiac arrythmias: multimodal assessment integrating body surface ECG mapping into cardiac imaging. Radiology. 2014; 271: 239-47.
138. Hunter RJ, Jones DA, Boubertakh R, Malcolme-Lawes LC, Kanagaratnam P, Juli CF, et al. Diagnostic accuracy of cardiac magnetic resonance imaging in the detection and characterization of left atrial catheter ablation lesions: a multicenter experience. J Cardiovasc Electrophysiol. 2013; 24: 396-403.
139. Menke J, Unterberg-Buchwald C, Staab W, Sohns JM, Seif Amir Hosseini A, Schwarz A. Head-To-head comparison of prospectively triggered vs retrospectively gated coronary computed tomography angiography: Meta-Analysis of diagnostic accuracy, image quality, and radiation dose. Am Heart J. 2013; 165: 154-63.e3.
140. Hatem SN, Sanders P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res. 2014; 102: 205-13.
141. Marwan M, Achenbach S. Quantification of epicardial fat by computed tomography: why, when and how?. J Cardiovasc Comput Tomogr. 2013; 7: 3-10.
142. Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med. 2005; 118: 489-95.
143. Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE, et al. The long- And short-Term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (Womens Health Study). J Am Coll Cardiol. 2010; 55: 2319-27.
144. Wang TJ, Parise H, Levy D, DAgostino RB Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004; 292: 2471-7.
145. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009; 374: 534-42.
146. Holmes DR Jr, Doshi SK, Kar S, Price MJ, Sanchez JM, Sievert H, et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-Analysis. J Am Coll Cardiol. 2015; 65: 2614-23.
147. Budge LP, Shaffer KM, Moorman JR, Lake DE, Ferguson JD, Mangrum JM. Analysis of in vivo left atrial appendage morphology in patients with atrial fibrillation: a direct comparison of transesophageal echocardiography, planar cardiac CT, and segmented three-dimensional cardiac CT. J Interv Card Electrophysiol. 2008; 23: 87-93.
148. Heist EK, Refaat M, Danik SB, Holmvang G, Ruskin JN, Mansour M. Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation. Heart Rhythm. 2006; 3: 1313-8.
149. Kimura T, Takatsuki S, Inagawa K, Katsumata Y, Nishiyama T, Nishiyama N, et al. Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores. Heart Rhythm. 2013; 10: 921-5.
150. Wang Y, Di Biase L, Horton RP, Nguyen T, Morhanty P, Natale A. Left atrial appendage studied by computed tomography to help planning for appendage closure device placement. J Cardiovasc Electrophysiol. 2010; 21: 973-82.
151. Lopez-Minguez JR, Gonzalez-Fernandez R, Fernandez-Vegas C, Millan-Nunez V, Fuentes-Canamero ME, Nogales-Asensio JM, et al. Anatomical classification of left atrial appendages in specimens applicable to CT imaging techniques for implantation of amplatzer cardiac plug. J Invasive Cardiol. 2014; 26: 462-7.
152. Zamorano JL, Badano LP, Bruce C, Chan KL, Goncalves A, Hahn RT, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J. 2011; 32: 2189-214.
153. Chyou JY, Biviano A, Magno P, Garan H, Einstein AJ. Applications of computed tomography and magnetic resonance imaging in percutaneous ablation therapy for atrial fibrillation. J Interv Card Electrophysiol. 2009; 26: 47-57.
154. Niinuma H, George RT, Arbab-Zadeh A, Lima JA, Henrikson CA. Imaging of pulmonary veins during catheter ablation for atrial fibrillation: the role of multi-slice computed tomography. Europace. 2008; 10(Suppl. 3): iii14-21.
155. Jongbloed MR, Bax JJ, Lamb HJ, Dirksen MS, Zeppenfeld K, van derWall EE, et al. Multislice computed tomography versus intracardiac echocardiography to evaluate the pulmonary veins before radiofrequency catheter ablation of atrial fibrillation: a head-To-head comparison. J Am Coll Cardiol. 2005; 45: 343-50.
156. Schwartzman D, Lacomis J, Wigginton WG. Characterization of left atrium and distal pulmonary vein morphology using multidimensional computed tomography. J Am Coll Cardiol. 2003; 41: 1349-57.
157. Wood MA, Wittkamp M, Henry D, Martin R, Nixon JV, Shepard RK, et al. A comparison of pulmonary vein ostial anatomy by computerized tomography, echocardiography, and venography in patients with atrial fibrillation having radiofrequency catheter ablation. Am J Cardiol. 2004; 93: 49-53.
158. Anter E, Silverstein J, Tschabrunn CM, Shvilkin A, Haffajee CI, Zimetbaum PJ, et al. Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages. Heart Rhythm. 2014; 11: 1890-7.
159. Romero J, Husain SA, Kelesidis I, Sanz J, Medina HM, Garcia MJ. Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-Analysis. Circ Cardiovasc Imaging. 2013; 6: 185-94.
160. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/.EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012 14 528-606.
161. Saad EB, Rossillo A, Saad CP, Martin DO, Bhargava M, Erciyes D, et al. Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy. Circulation. 2003; 108: 3102-7.
162. Ueda M, Tada H, Kurosaki K, Itoi K, Koyama K, Naito S, et al. Pulmonary vein morphology before and after segmental isolation in patients with atrial fibrillation. Pacing Clin Electrophysiol PACE. 2005; 28: 944-53.
163. DSilva A, Wright M. Advances in imaging for atrial fibrillation ablation. Radiol Res Practice. 2011; 2011: 714864.
164. Kistler PM, Rajappan K, Harris S, Earley MJ, Richmond L, Sporton SC, et al. The impact of image integration on catheter ablation of atrial fibrillation using electroanatomic mapping: a prospective randomized study. Eur Heart J. 2008; 29: 3029-36.
165. Kistler PM, Rajappan K, Jahngir M, Earley MJ, Harris S, Abrams D, et al. The impact of CT image integration into an electroanatomic mapping system on clinical outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2006; 17: 1093-101.
166. Martinek M, Nesser HJ, Aichinger J, Boehm G, Purerfellner H. Impact of integration of multislice computed tomography imaging into three-dimensional electroanatomic mapping on clinical outcomes, safety, and efficacy using radiofrequency ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2007; 30: 1215-23.
167. Sra J, Narayan G, Krum D, Malloy A, Cooley R, Bhatia A, et al. Computed tomography-fluoroscopy image integration-guided catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007; 18: 409-14.
168. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997; 96: 2455-61.
169. Grigioni F, Avierinos JF, Ling LH, Scott CG, Bailey KR, Tajik AJ, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-Term outcome. J Am Coll Cardiol. 2002; 40: 84-92.
170. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 129 e521-643.
171. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012; 33: 2451-96.
172. Gertz ZM, Raina A, Saghy L, Zado ES, Callans DJ, Marchlinski FE, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol. 2011; 58: 1474-81.
173. Zamorano J, Cordeiro P, Sugeng L, Perez de Isla L, Weinert L, Macaya C, et al. Realtime three-dimensional echocardiography for rheumatic mitral valve stenosis evaluation: an accurate and novel approach. J Am Coll Cardiol. 2004; 43: 2091-6.
174. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013; 14: 611-44.
175. Zamorano J, Perez de Isla L, Sugeng L, Cordeiro P, Rodrigo JL, Almeria C, et al. Non-invasive assessment of mitral valve area during percutaneous balloon mitral valvuloplasty: role of real-Time 3D echocardiography. Eur Heart J. 2004; 25: 2086-91.
176. Solis J, Sitges M, Levine RA, Hung J. Three-dimensional echocardiography. New possibilities in mitral valve assessment. Rev Esp Cardiol. 2009; 62: 188-98.
177. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012; 366: 1705-15.
178. Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5-Year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015 385 2485-91.
179. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015 385 2477-84.
180. Pilgrim T, Englberger L, Rothenbuhler M, Stortecky S, Ceylan O, OSullivan CJ, et al. Long-Term outcome of elderly patients with severe aortic stenosis as a function of treatment modality. Heart. 2015; 101: 30-6.
181. Stortecky S, Buellesfeld L, Wenaweser P, Heg D, Pilgrim T, Khattab AA, et al. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2013; 6: 77-84.
182. Saxena A, Dinh DT, Reid CM, Smith JA, Shardey GC, Newcomb AE. Does preoperative atrial fibrillation portend a poorer prognosis in patients undergoing isolated aortic valve replacement?. A multicentre Australian study. Can J Cardiol. 2013; 29: 697-703.
183. Najib MQ, Vinales KL, Vittala SS, Challa S, Lee HR, Chaliki HP. Predictors for the development of severe tricuspid regurgitation with anatomically normal valve in patients with atrial fibrillation. Echocardiography. 2012; 29: 140-6.
184. American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Echocardiography; American Heart Association; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Critical Care Medicine; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; American College of Chest Physicians, et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance E dorsed by the American College of Chest Physicians. J Am Coll Cardiol. 2011; 57: 1126-66.
185. Geleijnse ML, Krenning BJ, Nemes A, van Dalen BM, Soliman OI, Ten Cate FJ, et al. Incidence, pathophysiology, and treatment of complications during dobutamine-Atropine stress echocardiography. Circulation. 2010; 121: 1756-67.
186. Bouzas-Mosquera A, Peteiro J, Broullon FJ, Alvarez-Garcia N, Mosquera VX, Rodriguez-Vilela A, et al. Prognostic value of exercise echocardiography in patients with atrial fibrillation. Eur J Echocardiogr. 2010; 11: 346-51.
187. Sheldon SH, Askew JW III, Klarich KW, Scott CG, Pellikka PA, McCully RB. Occurrence of atrial fibrillation during dobutamine stress echocardiography: incidence, risk factors, and outcomes. J Am Soc Echocardiogr. 2011; 24: 86-90.
188. Senior R, Dwivedi G, Hayat S, Lim TK. Clinical benefits of contrast-enhanced echocardiography during rest and stress examinations. Eur J Echocardiogr. 2005; 6(Suppl 2): S6-13.
189. Senior R, Moreo A, Gaibazzi N, Agati L, Tiemann K, Shivalkar B, et al. Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study. J Am Coll Cardiol. 2013; 62: 1353-61.
190. Range FT, Schafers M, Acil T, Schafers KP, Kies P, Paul M, et al. Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation. Eur Heart J. 2007; 28: 2223-30.
191. Smit MD, Tio RA, Slart RH, Zijlstra F, Van Gelder IC. Myocardial perfusion imaging does not adequately assess the risk of coronary artery disease in patients with atrial fibrillation. Europace. 2010; 12: 643-8.
192. Nucifora G, Schuijf JD, van Werkhoven JM, Trines SA, Kajander S, Tops LF, et al. Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation. Int J Cardiovasc Imaging. 2011; 27: 777-85.
193. Gimelli A, Liga R, Startari U, Giorgetti A, Pieraccini L, Marzullo P. Evaluation of ischaemia in patients with atrial fibrillation: impact of stress protocol on myocardial perfusion imaging accuracy. Eur Heart J Cardiovasc Imaging. 2015; 16: 781-7.
194. Buber J, Glikson M, Eldar M, Luria D. Exercise heart rate acceleration patterns during atrial fibrillation and sinus rhythm. Ann Noninvasive Electrocardiol. 2011; 16: 357-64.
195. Hilliard AA, Miller TD, Hodge DO, Gibbons RJ. Heart rate control in patients with atrial fibrillation referred for exercise testing. Am J Cardiol. 2008; 102: 704-8.
196. Blomstrom Lundqvist C, Auricchio A, Brugada J, Boriani G, Bremerich J, Cabrera JA, et al. The use of imaging for electrophysiological and devices procedures: a report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology. Europace. 2013; 15: 927-36.
197. Wu RC, Brinker JA, Yuh DD, Berger RD, Calkins HG. Circular mapping catheter entrapment in the mitral valve apparatus: a previously unrecognized complication of focal atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2002; 13: 819-21.
198. Baran J, Stec S, Pilichowska-Paszkiet E, Zaborska B, Sikora-Frac M, Krynski T, et al. Intracardiac echocardiography for detection of thrombus in the left atrial appendage: comparison with transesophageal echocardiography in patients undergoing ablation for atrial fibrillation: the Action-Ice I Study. Circ Arrhythm Electrophysiol. 2013; 6: 1074-81.
199. Bulava A, Hanis J, Eisenberger M. Catheter ablation of atrial fibrillation using zerofluoroscopy technique: a randomized trial. Pacing Clin Electrophysiol. 2015; 38: 797-806.
200. Clemente A, Avogliero F, Berti S, Paradossi U, Jamagidze G, Rezzaghi M, et al. Multimodality imaging in preoperative assessment of left atrial appendage transcatheter occlusion with the Amplatzer Cardiac Plug. Eur Heart J Cardiovasc Imaging. 2015; 16: 1276-87.
201. Donal E, Grimm RA, Yamada H, Kim YJ, Marrouche N, Natale A, et al. Usefulness of Doppler assessment of pulmonary vein and left atrial appendage flow following pulmonary vein isolation of chronic atrial fibrillation in predicting recovery of left atrial function. Am J Cardiol. 2005; 95: 941-7.
202. Ren JF, Marchlinski FE, Callans DJ, Zado ES. Intracardiac Doppler echocardiographic quantification of pulmonary vein flow velocity: an effective technique for monitoring pulmonary vein ostia narrowing during focal atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2002; 13: 1076-81.
203. Saksena S, Sra J, Jordaens L, Kusumoto F, Knight B, Natale A, et al. A prospective comparison of cardiac imaging using intracardiac echocardiography with transesophageal echocardiography in patients with atrial fibrillation: the intracardiac echocardiography guided cardioversion helps interventional procedures study. Circ Arrhythm Electrophysiol. 2010; 3: 571-7.
204. Hwang HJ, Choi EY, Rhee SJ, Joung B, Lee BH, Lee SH, et al. Left atrial strain as predictor of successful outcomes in catheter ablation for atrial fibrillation: a twodimensional myocardial imaging study. J Interv Card Electrophysiol. 2009; 26: 127-32.
205. Kuppahally SS, Akoum N, Badger TJ, Burgon NS, Haslam T, Kholmovski E, et al. Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging. Am Heart J. 2010; 160: 877-84.
206. Okada T, Yamada T, Murakami Y, Yoshida N, Ninomiya Y, Shimizu T, et al. Prevalence and severity of left atrial edema detected by electron beam tomography early after pulmonary vein ablation. J Am Coll Cardiol. 2007; 49: 1436-42.
207. Kato R, Lickfett L, Meininger G, Dickfeld T, Wu R, Juang G, et al. Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation: lessons learned by use of magnetic resonance imaging. Circulation. 2003; 107: 2004-10.
208. Arentz T, Jander N, von Rosenthal J, Blum T, Furmaier R, Gornandt L, et al. Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation. Eur Heart J. 2003; 24: 963-9.
209. Arentz T, Weber R, Jander N, Burkle G, von Rosenthal J, Blum T, et al. Pulmonary haemodynamics at rest and during exercise in patients with significant pulmonary vein stenosis after radiofrequency catheter ablation for drug resistant atrial fibrillation. Eur Heart J. 2005; 26: 1410-4.
210. Bax JJ, Marsan NA, Delgado V. Non-invasive imaging in atrial fibrillation: focus on prognosis and catheter ablation. Heart. 2015; 101: 94-100.
211. Nucifora G, Faletra FF, Regoli F, Pasotti E, Pedrazzini G, Moccetti T, et al. Evaluation of the left atrial appendage with real-Time 3-dimensional transesophageal echocardiography: implications for catheter-based left atrial appendage closure. Circ Cardiovasc Imaging. 2011; 4: 514-23.
212. Yamamoto M, Seo Y, Kawamatsu N, Sato K, Sugano A, Machino-Ohtsuka T, et al. Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation. Circ Cardiovasc Imaging. 2014; 7: 337-43.
213. Anselmino M, Scaglione M, Di Biase L, Gili S, Santangeli P, Corsinovi L, et al. Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation. Heart Rhythm. 2014; 11: 2-7.
214. Theriault-Lauzier P, Andalib A, Martucci G, Mylotte D, Cecere R, Lange R, et al. Fluoroscopic anatomy of left-sided heart structures for transcatheter interventions: insight from multislice computed tomography. JACC Cardiovasc Interv. 2014; 7: 947-57.
215. Kar S, Hou D, Jones R, Werner D, Swanson L, Tischler B, et al. Impact ofWatchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model. JACC Cardiovasc Interv. 2014; 7: 801-9.
216. Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial. Circulation. 2013; 127: 720-9.
217. Mraz T, Neuzil P, Mandysova E, Niederle P, Reddy VY. Role of echocardiography in percutaneous occlusion of the left atrial appendage. Echocardiography. 2007; 24: 401-4.
218. Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of theWatchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-Term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014; 64: 1-12.
219. Waksman R, Pendyala LK. Overview of the Food and Drug Administration circulatory system devices panel meetings onWATCHMAN left atrial appendage closure therapy. Am J Cardiol. 2015; 115: 378-84.
220. Urena M, Rodes-Cabau J, Freixa X, Saw J, Webb JG, Freeman M, et al. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol. 2013; 62: 96-102.
221. Ferguson JD, Helms A, Mangrum JM, Mahapatra S, Mason P, Bilchick K, et al. Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping. Circ Arrhythm Electrophysiol. 2009; 2: 611-9.
222. Helms A, West JJ, Patel A, Mounsey JP, DiMarco JP, Mangrum JM, et al. Real-Time rotational ICE imaging of the relationship of the ablation catheter tip and the esophagus during atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2009; 20: 130-7.
223. Nordbeck P, Beer M, Kostler H, Ladd ME, Quick HH, Bauer WR, et al. Cardiac catheter ablation under real-Time magnetic resonance guidance. Eur Heart J. 2012; 33: 1977.